| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | actin filament binding | 1.09e-05 | 227 | 67 | 7 | GO:0051015 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | APPBP2 NRAP ALMS1 SMC3 SYNE1 SPTAN1 NCKIPSD GNAS PLEC MYO18B NEB IQGAP3 EML3 KPNB1 | 1.36e-05 | 1099 | 67 | 14 | GO:0008092 |
| GeneOntologyMolecularFunction | group III metabotropic glutamate receptor activity | 6.63e-05 | 4 | 67 | 2 | GO:0001642 | |
| GeneOntologyMolecularFunction | G protein-coupled glutamate receptor activity | 3.93e-04 | 9 | 67 | 2 | GO:0098988 | |
| GeneOntologyMolecularFunction | adenylate cyclase inhibiting G protein-coupled glutamate receptor activity | 3.93e-04 | 9 | 67 | 2 | GO:0001640 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 6.67e-04 | 118 | 67 | 4 | GO:0003774 | |
| GeneOntologyMolecularFunction | actin binding | 1.10e-03 | 479 | 67 | 7 | GO:0003779 | |
| GeneOntologyBiologicalProcess | organelle assembly | NRAP ALMS1 TCHP SMC3 CFAP97D1 SYNE1 PLEC NEB BBS9 EML3 DYNC1H1 VPS13B IQUB DHX30 KPNB1 | 2.81e-06 | 1138 | 67 | 15 | GO:0070925 |
| GeneOntologyBiologicalProcess | ultradian rhythm | 1.04e-05 | 2 | 67 | 2 | GO:0007624 | |
| GeneOntologyBiologicalProcess | membraneless organelle assembly | 2.21e-05 | 475 | 67 | 9 | GO:0140694 | |
| GeneOntologyBiologicalProcess | cardiac muscle thin filament assembly | 3.11e-05 | 3 | 67 | 2 | GO:0071691 | |
| GeneOntologyBiologicalProcess | actomyosin contractile ring assembly actin filament organization | 6.21e-05 | 4 | 67 | 2 | GO:2000689 | |
| GeneOntologyBiologicalProcess | actomyosin structure organization | 1.26e-04 | 239 | 67 | 6 | GO:0031032 | |
| GeneOntologyBiologicalProcess | cellular anatomical entity morphogenesis | 1.54e-04 | 156 | 67 | 5 | GO:0032989 | |
| GeneOntologyBiologicalProcess | cellular component assembly involved in morphogenesis | 1.54e-04 | 156 | 67 | 5 | GO:0010927 | |
| GeneOntologyCellularComponent | sarcomere | 1.48e-05 | 249 | 67 | 7 | GO:0030017 | |
| GeneOntologyCellularComponent | myofibril | 2.67e-05 | 273 | 67 | 7 | GO:0030016 | |
| GeneOntologyCellularComponent | contractile muscle fiber | 3.93e-05 | 290 | 67 | 7 | GO:0043292 | |
| GeneOntologyCellularComponent | Z disc | 1.24e-04 | 151 | 67 | 5 | GO:0030018 | |
| GeneOntologyCellularComponent | muscle tendon junction | 1.51e-04 | 6 | 67 | 2 | GO:0005927 | |
| GeneOntologyCellularComponent | I band | 1.93e-04 | 166 | 67 | 5 | GO:0031674 | |
| GeneOntologyCellularComponent | supramolecular fiber | APPBP2 NRAP TCHP SYNE1 SPTAN1 NCKIPSD STYXL2 PLEC MYO18B NEB EML3 DYNC1H1 | 3.29e-04 | 1179 | 67 | 12 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | APPBP2 NRAP TCHP SYNE1 SPTAN1 NCKIPSD STYXL2 PLEC MYO18B NEB EML3 DYNC1H1 | 3.50e-04 | 1187 | 67 | 12 | GO:0099081 |
| GeneOntologyCellularComponent | fascia adherens | 7.72e-04 | 13 | 67 | 2 | GO:0005916 | |
| GeneOntologyCellularComponent | cell cortex | 1.20e-03 | 371 | 67 | 6 | GO:0005938 | |
| HumanPheno | Abnormal palm morphology | KMT2D ITCH SMC3 OTUD5 MMP1 PLEC SMC5 BCR DYNC1H1 VPS13B DHX30 | 8.33e-06 | 521 | 24 | 11 | HP:0100871 |
| HumanPheno | Hyperostosis frontalis interna | 2.13e-05 | 2 | 24 | 2 | HP:0004438 | |
| HumanPheno | Truncal obesity | 3.20e-05 | 82 | 24 | 5 | HP:0001956 | |
| HumanPheno | Motor delay | KMT2D ITCH ALMS1 SMC3 SYNE1 SPTAN1 NBEA PLEC MYO18B NEB SMC5 DYNC1H1 VPS13B DHX30 | 3.88e-05 | 1018 | 24 | 14 | HP:0001270 |
| HumanPheno | Hirsutism | 4.18e-05 | 216 | 24 | 7 | HP:0001007 | |
| HumanPheno | Abnormal skin morphology of the palm | 6.03e-05 | 413 | 24 | 9 | HP:0040211 | |
| HumanPheno | Bilateral facial palsy | 6.36e-05 | 3 | 24 | 2 | HP:0430025 | |
| HumanPheno | Abnormality of the palmar creases | 1.36e-04 | 260 | 24 | 7 | HP:0010490 | |
| HumanPheno | Abnormal pinna morphology | FRMD4A KMT2D ITCH ALMS1 SMC3 OTUD5 SYNE1 PLEC MYO18B NEB SMC5 BCR BBS9 VPS13B DHX30 | 1.37e-04 | 1299 | 24 | 15 | HP:0000377 |
| HumanPheno | Abnormal palmar dermatoglyphics | 1.53e-04 | 265 | 24 | 7 | HP:0001018 | |
| HumanPheno | Thoracic scoliosis | 1.55e-04 | 60 | 24 | 4 | HP:0002943 | |
| HumanPheno | Abnormality of the outer ear | FRMD4A KMT2D ITCH ALMS1 SMC3 OTUD5 SYNE1 PLEC MYO18B NEB SMC5 BCR BBS9 VPS13B DHX30 | 1.95e-04 | 1337 | 24 | 15 | HP:0000356 |
| HumanPheno | Abnormal joint physiology | KMT2D ITCH SMC3 OTUD5 SYNE1 SPTAN1 MMP1 GNAS PLEC MYO18B NEB BCR BBS9 VPS13B DHX30 | 2.36e-04 | 1358 | 24 | 15 | HP:0034430 |
| HumanPheno | Abnormality of joint mobility | KMT2D ITCH SMC3 OTUD5 SYNE1 SPTAN1 MMP1 GNAS PLEC MYO18B NEB BCR BBS9 VPS13B DHX30 | 2.36e-04 | 1358 | 24 | 15 | HP:0011729 |
| HumanPheno | Ankyloglossia | 3.10e-04 | 29 | 24 | 3 | HP:0010296 | |
| HumanPheno | Upper eyelid edema | 3.15e-04 | 6 | 24 | 2 | HP:0012724 | |
| HumanPheno | Elevated circulating thyroid-stimulating hormone concentration | 3.43e-04 | 30 | 24 | 3 | HP:0002925 | |
| HumanPheno | Single transverse palmar crease | 3.74e-04 | 215 | 24 | 6 | HP:0000954 | |
| HumanPheno | Abnormal dermatoglyphics | 4.39e-04 | 314 | 24 | 7 | HP:0007477 | |
| HumanPheno | Decreased cervical spine flexion due to contractures of posterior cervical muscles | 4.40e-04 | 7 | 24 | 2 | HP:0004631 | |
| HumanPheno | Facial hyperostosis | 4.40e-04 | 7 | 24 | 2 | HP:0005465 | |
| HumanPheno | Hyperlordosis | 4.45e-04 | 222 | 24 | 6 | HP:0003307 | |
| HumanPheno | Lordosis | 4.45e-04 | 222 | 24 | 6 | HP:0002939 | |
| HumanPheno | Regional abnormality of skin | 4.85e-04 | 541 | 24 | 9 | HP:0011356 | |
| HumanPheno | Obesity | 4.88e-04 | 425 | 24 | 8 | HP:0001513 | |
| HumanPheno | Hypertrichosis | 4.88e-04 | 425 | 24 | 8 | HP:0000998 | |
| HumanPheno | Abnormal hair pattern | 5.38e-04 | 676 | 24 | 10 | HP:0010720 | |
| HumanPheno | Nasolacrimal duct obstruction | 5.93e-04 | 36 | 24 | 3 | HP:0000579 | |
| Domain | KRAB | 2.93e-05 | 358 | 64 | 8 | PS50805 | |
| Domain | KRAB | 2.93e-05 | 358 | 64 | 8 | PF01352 | |
| Domain | KRAB | 3.63e-05 | 369 | 64 | 8 | SM00349 | |
| Domain | KRAB | 3.70e-05 | 370 | 64 | 8 | IPR001909 | |
| Domain | NEBU | 6.90e-05 | 4 | 64 | 2 | SM00227 | |
| Domain | Nebulin | 6.90e-05 | 4 | 64 | 2 | PF00880 | |
| Domain | Nebulin | 6.90e-05 | 4 | 64 | 2 | IPR013998 | |
| Domain | NEBULIN | 6.90e-05 | 4 | 64 | 2 | PS51216 | |
| Domain | Nebulin_repeat | 6.90e-05 | 4 | 64 | 2 | IPR000900 | |
| Domain | Spectrin_repeat | 1.32e-04 | 29 | 64 | 3 | IPR002017 | |
| Domain | Spectrin/alpha-actinin | 1.77e-04 | 32 | 64 | 3 | IPR018159 | |
| Domain | SPEC | 1.77e-04 | 32 | 64 | 3 | SM00150 | |
| Domain | IQ | 2.91e-04 | 93 | 64 | 4 | PS50096 | |
| Domain | RecF/RecN/SMC_N | 3.19e-04 | 8 | 64 | 2 | IPR003395 | |
| Domain | SMC_N | 3.19e-04 | 8 | 64 | 2 | PF02463 | |
| Domain | GPCR_3_mtglu_rcpt | 3.19e-04 | 8 | 64 | 2 | IPR000162 | |
| Domain | zf-C2H2_6 | 7.12e-04 | 314 | 64 | 6 | PF13912 | |
| Domain | NCD3G | 8.80e-04 | 13 | 64 | 2 | PF07562 | |
| Domain | GPCR_3_9-Cys_dom | 8.80e-04 | 13 | 64 | 2 | IPR011500 | |
| Domain | IMPORTIN_B_NT | 1.02e-03 | 14 | 64 | 2 | PS50166 | |
| Domain | GPCR_3_CS | 1.02e-03 | 14 | 64 | 2 | IPR017979 | |
| Domain | IBN_N | 1.18e-03 | 15 | 64 | 2 | PF03810 | |
| Domain | Post-SET_dom | 1.34e-03 | 16 | 64 | 2 | IPR003616 | |
| Domain | PostSET | 1.34e-03 | 16 | 64 | 2 | SM00508 | |
| Domain | IBN_N | 1.34e-03 | 16 | 64 | 2 | SM00913 | |
| Domain | POST_SET | 1.34e-03 | 16 | 64 | 2 | PS50868 | |
| Domain | CH | 1.44e-03 | 65 | 64 | 3 | SM00033 | |
| Domain | Importin-beta_N | 1.52e-03 | 17 | 64 | 2 | IPR001494 | |
| Domain | Pept_M10A_stromelysin-type | 1.71e-03 | 18 | 64 | 2 | IPR016293 | |
| Domain | CH | 1.78e-03 | 70 | 64 | 3 | PF00307 | |
| Domain | - | 1.86e-03 | 71 | 64 | 3 | 1.10.418.10 | |
| Domain | CH | 2.01e-03 | 73 | 64 | 3 | PS50021 | |
| Domain | PG_binding_1 | 2.11e-03 | 20 | 64 | 2 | PF01471 | |
| Domain | Peptidoglycan-bd-like | 2.11e-03 | 20 | 64 | 2 | IPR002477 | |
| Domain | - | 2.15e-03 | 679 | 64 | 8 | 3.30.160.60 | |
| Domain | CH-domain | 2.17e-03 | 75 | 64 | 3 | IPR001715 | |
| Domain | GPCR_3 | 2.33e-03 | 21 | 64 | 2 | IPR000337 | |
| Domain | SH3_1 | 2.42e-03 | 164 | 64 | 4 | PF00018 | |
| Domain | zf-C2H2 | 2.44e-03 | 693 | 64 | 8 | PF00096 | |
| Domain | Znf_C2H2/integrase_DNA-bd | 2.46e-03 | 694 | 64 | 8 | IPR013087 | |
| Domain | 7tm_3 | 2.55e-03 | 22 | 64 | 2 | PF00003 | |
| Domain | G_PROTEIN_RECEP_F3_2 | 2.55e-03 | 22 | 64 | 2 | PS00980 | |
| Domain | G_PROTEIN_RECEP_F3_3 | 2.55e-03 | 22 | 64 | 2 | PS00981 | |
| Domain | G_PROTEIN_RECEP_F3_1 | 2.55e-03 | 22 | 64 | 2 | PS00979 | |
| Domain | G_PROTEIN_RECEP_F3_4 | 2.55e-03 | 22 | 64 | 2 | PS50259 | |
| Domain | GPCR_3_C | 2.55e-03 | 22 | 64 | 2 | IPR017978 | |
| Domain | IQ | 2.71e-03 | 81 | 64 | 3 | SM00015 | |
| Domain | Actinin_actin-bd_CS | 2.79e-03 | 23 | 64 | 2 | IPR001589 | |
| Domain | Hemopexin-like_dom | 2.79e-03 | 23 | 64 | 2 | IPR000585 | |
| Domain | Hemopexin-like_repeat | 2.79e-03 | 23 | 64 | 2 | IPR018487 | |
| Domain | Spectrin | 2.79e-03 | 23 | 64 | 2 | PF00435 | |
| Domain | M10A_MMP | 2.79e-03 | 23 | 64 | 2 | IPR033739 | |
| Domain | Hemopexin | 2.79e-03 | 23 | 64 | 2 | PF00045 | |
| Domain | HEMOPEXIN | 2.79e-03 | 23 | 64 | 2 | PS00024 | |
| Domain | ACTININ_2 | 2.79e-03 | 23 | 64 | 2 | PS00020 | |
| Domain | - | 2.79e-03 | 23 | 64 | 2 | 2.110.10.10 | |
| Domain | HEMOPEXIN_2 | 2.79e-03 | 23 | 64 | 2 | PS51642 | |
| Domain | ACTININ_1 | 2.79e-03 | 23 | 64 | 2 | PS00019 | |
| Domain | HX | 2.79e-03 | 23 | 64 | 2 | SM00120 | |
| Domain | Pept_M10A | 2.79e-03 | 23 | 64 | 2 | IPR021190 | |
| Domain | Peptidase_M10 | 3.04e-03 | 24 | 64 | 2 | PF00413 | |
| Domain | IQ_motif_EF-hand-BS | 3.65e-03 | 90 | 64 | 3 | IPR000048 | |
| Domain | ZnMc | 4.42e-03 | 29 | 64 | 2 | SM00235 | |
| Domain | Peptidase_Metallo | 4.42e-03 | 29 | 64 | 2 | IPR006026 | |
| Domain | ZINC_PROTEASE | 4.63e-03 | 98 | 64 | 3 | PS00142 | |
| Pubmed | HENA, heterogeneous network-based data set for Alzheimer's disease. | 9.86e-11 | 120 | 68 | 8 | 31413325 | |
| Pubmed | NudCL2 regulates cell migration by stabilizing both myosin-9 and LIS1 with Hsp90. | 1.82e-08 | 333 | 68 | 9 | 32665550 | |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | RCOR1 TCHP SMC3 XPO6 CD2BP2 MIOS STYXL2 PLEC BCR BBS9 IQGAP3 DYNC1H1 DHX30 KPNB1 SRSF12 | 3.05e-08 | 1321 | 68 | 15 | 27173435 |
| Pubmed | TNIP2 is a Hub Protein in the NF-κB Network with Both Protein and RNA Mediated Interactions. | ITCH ENOX1 OTUD5 TNIP2 SPTAN1 NIPSNAP2 GNAS IQGAP3 ABHD17C DHX30 KPNB1 ENOX2 | 2.09e-07 | 922 | 68 | 12 | 27609421 |
| Pubmed | 5.31e-07 | 151 | 68 | 6 | 17043677 | ||
| Pubmed | 5.40e-07 | 497 | 68 | 9 | 23414517 | ||
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | RCOR1 SMC3 SYNE1 CD2BP2 GNAS SMC5 IQGAP3 EML3 DYNC1H1 VPS13B DHX30 KPNB1 | 2.23e-06 | 1155 | 68 | 12 | 20360068 |
| Pubmed | LCP1 preferentially binds clasped αMβ2 integrin and attenuates leukocyte adhesion under flow. | 5.03e-06 | 344 | 68 | 7 | 30333137 | |
| Pubmed | SETMAR ITCH SYNE1 ZNF92 SPTAN1 CUL9 NBEA PLCG1 PLEC DYNC1H1 DHX30 KPNB1 | 6.61e-06 | 1285 | 68 | 12 | 35914814 | |
| Pubmed | 6.72e-06 | 234 | 68 | 6 | 36243803 | ||
| Pubmed | Identification of novel spartin-interactors shows spartin is a multifunctional protein. | 6.77e-06 | 19 | 68 | 3 | 19765186 | |
| Pubmed | 7.30e-06 | 63 | 68 | 4 | 37052853 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | KMT2D XPO6 CD2BP2 CUL9 PLCG1 PLEC BCR IQGAP3 EML3 DYNC1H1 DHX30 | 9.26e-06 | 1105 | 68 | 11 | 35748872 |
| Pubmed | Nuclear import and subnuclear localization of the proto-oncoprotein ETO (MTG8). | 1.13e-05 | 3 | 68 | 2 | 10951564 | |
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 23538446 | ||
| Pubmed | Homologs of Drosophila Fushi-Tarazu factor 1 map to mouse chromosome 2 and human chromosome 9q33. | 1.13e-05 | 3 | 68 | 2 | 7789992 | |
| Pubmed | 1.25e-05 | 152 | 68 | 5 | 34299191 | ||
| Pubmed | 1.50e-05 | 407 | 68 | 7 | 12693553 | ||
| Pubmed | 1.72e-05 | 963 | 68 | 10 | 28671696 | ||
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | 1.79e-05 | 582 | 68 | 8 | 20467437 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | 1.93e-05 | 588 | 68 | 8 | 38580884 | |
| Pubmed | Nucleolin-Mediated RNA Localization Regulates Neuron Growth and Cycling Cell Size. | 2.25e-05 | 4 | 68 | 2 | 27477284 | |
| Pubmed | TRPM1 is a component of the retinal ON bipolar cell transduction channel in the mGluR6 cascade. | 2.25e-05 | 4 | 68 | 2 | 19966281 | |
| Pubmed | Distribution of group-III metabotropic glutamate receptors in the retina. | 2.25e-05 | 4 | 68 | 2 | 17311335 | |
| Pubmed | 2.63e-05 | 87 | 68 | 4 | 12465718 | ||
| Pubmed | Comparative interactome analysis of α-arrestin families in human and Drosophila. | 3.47e-05 | 313 | 68 | 6 | 38270169 | |
| Pubmed | 3.75e-05 | 5 | 68 | 2 | 3027087 | ||
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | 4.81e-05 | 332 | 68 | 6 | 32786267 | |
| Pubmed | Pias1 interaction and sumoylation of metabotropic glutamate receptor 8. | 5.62e-05 | 6 | 68 | 2 | 16144832 | |
| Pubmed | Cutting edge: integration of human T lymphocyte cytoskeleton by the cytolinker plectin. | 5.62e-05 | 6 | 68 | 2 | 11441066 | |
| Pubmed | 5.62e-05 | 6 | 68 | 2 | 18827015 | ||
| Pubmed | Dysregulation of NRAP degradation by KLHL41 contributes to pathophysiology in nemaline myopathy. | 5.62e-05 | 6 | 68 | 2 | 30986853 | |
| Pubmed | 6.40e-05 | 214 | 68 | 5 | 22199357 | ||
| Pubmed | 7.52e-05 | 360 | 68 | 6 | 33111431 | ||
| Pubmed | 7.86e-05 | 7 | 68 | 2 | 9920659 | ||
| Pubmed | 7.86e-05 | 7 | 68 | 2 | 1383690 | ||
| Pubmed | 7.86e-05 | 7 | 68 | 2 | 26195665 | ||
| Pubmed | 8.11e-05 | 225 | 68 | 5 | 12168954 | ||
| Pubmed | Transcription factor Foxp3 and its protein partners form a complex regulatory network. | 8.74e-05 | 370 | 68 | 6 | 22922362 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | SMC3 SYNE1 SPTAN1 PLCG1 GNAS MYO18B HNRNPLL IQGAP3 DYNC1H1 DHX30 KPNB1 | 9.41e-05 | 1425 | 68 | 11 | 30948266 |
| Pubmed | RCOR1 KMT2D ALMS1 MRS2 SMC3 TNIP2 SPTAN1 CD2BP2 CUL9 DYNC1H1 DHX30 | 9.65e-05 | 1429 | 68 | 11 | 35140242 | |
| Pubmed | SYNE1 SPTAN1 NCKIPSD MIOS NIPSNAP2 NBEA PLEC BCR DYNC1H1 DHX30 KPNB1 | 9.77e-05 | 1431 | 68 | 11 | 37142655 | |
| Pubmed | 1.14e-04 | 242 | 68 | 5 | 34011540 | ||
| Pubmed | The role of a lymphoid-restricted, Grb2-like SH3-SH2-SH3 protein in T cell receptor signaling. | 1.34e-04 | 9 | 68 | 2 | 8995379 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | ITCH SMC3 SPTAN1 CD2BP2 GNAS PLEC IQGAP3 DYNC1H1 DHX30 KPNB1 | 1.59e-04 | 1257 | 68 | 10 | 36526897 |
| Pubmed | Scc1 sumoylation by Mms21 promotes sister chromatid recombination through counteracting Wapl. | 1.68e-04 | 10 | 68 | 2 | 22751501 | |
| Pubmed | Expression cloning of GABA(B) receptors uncovers similarity to metabotropic glutamate receptors. | 1.68e-04 | 10 | 68 | 2 | 9069281 | |
| Pubmed | 1.78e-04 | 604 | 68 | 7 | 38803224 | ||
| Pubmed | 1.84e-04 | 56 | 68 | 3 | 23934736 | ||
| Pubmed | 1.97e-04 | 272 | 68 | 5 | 31010829 | ||
| Pubmed | 2.02e-04 | 147 | 68 | 4 | 16959763 | ||
| Pubmed | 2.03e-04 | 274 | 68 | 5 | 34244482 | ||
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | 2.29e-04 | 281 | 68 | 5 | 28706196 | |
| Pubmed | 2.41e-04 | 446 | 68 | 6 | 24255178 | ||
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | 2.51e-04 | 1082 | 68 | 9 | 38697112 | |
| Pubmed | 2.54e-04 | 156 | 68 | 4 | 22952844 | ||
| Pubmed | 3.60e-04 | 481 | 68 | 6 | 28190767 | ||
| Pubmed | Interspecific backcross mice show sex-specific differences in allelic inheritance. | 3.89e-04 | 15 | 68 | 2 | 1916246 | |
| Pubmed | 3.89e-04 | 15 | 68 | 2 | 17925232 | ||
| Pubmed | The protein interaction landscape of the human CMGC kinase group. | 4.16e-04 | 695 | 68 | 7 | 23602568 | |
| Pubmed | 4.27e-04 | 322 | 68 | 5 | 26514267 | ||
| Pubmed | 4.33e-04 | 323 | 68 | 5 | 24797263 | ||
| Pubmed | KLHL40 deficiency destabilizes thin filament proteins and promotes nemaline myopathy. | 4.44e-04 | 16 | 68 | 2 | 24960163 | |
| Pubmed | 4.44e-04 | 16 | 68 | 2 | 16944923 | ||
| Pubmed | 4.70e-04 | 329 | 68 | 5 | 17474147 | ||
| Pubmed | 4.90e-04 | 332 | 68 | 5 | 37433992 | ||
| Pubmed | 5.04e-04 | 187 | 68 | 4 | 26460568 | ||
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | 5.19e-04 | 949 | 68 | 8 | 36574265 | |
| Pubmed | 5.27e-04 | 80 | 68 | 3 | 35803934 | ||
| Pubmed | 5.46e-04 | 191 | 68 | 4 | 33762435 | ||
| Pubmed | The proximal signaling network of the BCR-ABL1 oncogene shows a modular organization. | 5.47e-04 | 81 | 68 | 3 | 20697350 | |
| Pubmed | 5.65e-04 | 18 | 68 | 2 | 19961560 | ||
| Pubmed | 5.87e-04 | 83 | 68 | 3 | 28794006 | ||
| Pubmed | The protein network surrounding the human telomere repeat binding factors TRF1, TRF2, and POT1. | 6.13e-04 | 197 | 68 | 4 | 20811636 | |
| Pubmed | 6.48e-04 | 538 | 68 | 6 | 28524877 | ||
| Pubmed | 6.74e-04 | 87 | 68 | 3 | 20801516 | ||
| Pubmed | 7.00e-04 | 20 | 68 | 2 | 15967462 | ||
| Pubmed | 7.00e-04 | 1247 | 68 | 9 | 27684187 | ||
| Pubmed | USP53 plays an antitumor role in hepatocellular carcinoma through deubiquitination of cytochrome c. | 7.44e-04 | 90 | 68 | 3 | 35654790 | |
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | 7.54e-04 | 1005 | 68 | 8 | 19615732 | |
| Pubmed | ARRDC1 and ARRDC3 act as tumor suppressors in renal cell carcinoma by facilitating YAP1 degradation. | 7.72e-04 | 21 | 68 | 2 | 29416926 | |
| Pubmed | Quantitative analysis of PPT1 interactome in human neuroblastoma cells. | 7.78e-04 | 210 | 68 | 4 | 26217791 | |
| Pubmed | Large-scale identification of c-MYC-associated proteins using a combined TAP/MudPIT approach. | 7.91e-04 | 211 | 68 | 4 | 17314511 | |
| Pubmed | 8.08e-04 | 371 | 68 | 5 | 25241761 | ||
| Pubmed | Functional interactions between matrix metalloproteinases and glycosaminoglycans. | 8.48e-04 | 22 | 68 | 2 | 23421805 | |
| Pubmed | 8.48e-04 | 22 | 68 | 2 | 36877136 | ||
| Pubmed | HEY1 functions are regulated by its phosphorylation at Ser-68. | 8.70e-04 | 95 | 68 | 3 | 27129302 | |
| Pubmed | 9.05e-04 | 1293 | 68 | 9 | 15342556 | ||
| Pubmed | Biochemical Reduction of the Topology of the Diverse WDR76 Protein Interactome. | 9.09e-04 | 219 | 68 | 4 | 31353912 | |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | 1.00e-03 | 807 | 68 | 7 | 30575818 | |
| Pubmed | Glutamate can act as a signaling molecule in mouse preimplantation embryos†. | 1.01e-03 | 24 | 68 | 2 | 35746896 | |
| Pubmed | 1.01e-03 | 24 | 68 | 2 | 33705438 | ||
| Pubmed | 1.05e-03 | 591 | 68 | 6 | 15231748 | ||
| Pubmed | 1.09e-03 | 397 | 68 | 5 | 21319273 | ||
| Pubmed | NDP52 interacts with mitochondrial RNA poly(A) polymerase to promote mitophagy. | 1.10e-03 | 25 | 68 | 2 | 30309841 | |
| Pubmed | 1.10e-03 | 25 | 68 | 2 | 20301702 | ||
| Pubmed | 1.13e-03 | 104 | 68 | 3 | 9205841 | ||
| Pubmed | 1.19e-03 | 26 | 68 | 2 | 24067654 | ||
| Pubmed | 1.22e-03 | 237 | 68 | 4 | 29564676 | ||
| Pubmed | 1.28e-03 | 27 | 68 | 2 | 37995181 | ||
| Interaction | MECOM interactions | 3.12e-06 | 358 | 68 | 9 | int:MECOM | |
| Interaction | NUDCD2 interactions | 1.22e-05 | 424 | 68 | 9 | int:NUDCD2 | |
| Interaction | DISC1 interactions | 1.34e-05 | 429 | 68 | 9 | int:DISC1 | |
| Interaction | MYO18B interactions | 1.62e-05 | 15 | 68 | 3 | int:MYO18B | |
| Interaction | ENOX1 interactions | 4.02e-05 | 20 | 68 | 3 | int:ENOX1 | |
| Interaction | DYNLL1 interactions | 5.19e-05 | 510 | 68 | 9 | int:DYNLL1 | |
| Interaction | SUZ12 interactions | 5.66e-05 | 644 | 68 | 10 | int:SUZ12 | |
| Interaction | ACTB interactions | RCOR1 NRAP ALMS1 TCHP SMC3 XPO6 TNIP2 SPTAN1 PLEC MYO18B NEB SMC5 DYNC1H1 | 5.76e-05 | 1083 | 68 | 13 | int:ACTB |
| Interaction | GFI1 interactions | 7.07e-05 | 24 | 68 | 3 | int:GFI1 | |
| Interaction | AGAP2 interactions | 7.62e-05 | 210 | 68 | 6 | int:AGAP2 | |
| Interaction | CDCA5 interactions | 1.10e-04 | 140 | 68 | 5 | int:CDCA5 | |
| Interaction | RABL2A interactions | 1.13e-04 | 28 | 68 | 3 | int:RABL2A | |
| Cytoband | 7q11.21 | 2.62e-04 | 83 | 68 | 3 | 7q11.21 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 9.75e-05 | 718 | 48 | 9 | 28 | |
| GeneFamily | Structural maintenance of chromosomes proteins|Cohesin complex | 1.44e-04 | 7 | 48 | 2 | 761 | |
| GeneFamily | Glutamate metabotropic receptors|Protein phosphatase 1 regulatory subunits | 1.91e-04 | 8 | 48 | 2 | 281 | |
| GeneFamily | Endogenous ligands|Matrix metallopeptidases | 1.84e-03 | 24 | 48 | 2 | 891 | |
| GeneFamily | RNA binding motif containing | 2.43e-03 | 213 | 48 | 4 | 725 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 4.10e-03 | 36 | 48 | 2 | 823 | |
| GeneFamily | Phospholipases | 5.55e-03 | 42 | 48 | 2 | 467 | |
| Coexpression | PARENT_MTOR_SIGNALING_UP | 1.54e-05 | 567 | 68 | 9 | M16909 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | KMT2D SMC3 OTUD5 XPO6 SYNE1 SPTAN1 PLCG1 GNAS SMC5 HNRNPLL EML3 DYNC1H1 VPS13B KPNB1 | 2.40e-05 | 1492 | 68 | 14 | M40023 |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.87e-07 | 198 | 68 | 6 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 | |
| ToppCell | facs-Lung-nan-3m-Endothelial-vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.24e-06 | 170 | 68 | 5 | 67d7e1da3ebd2d14cb2e67799e94d655027ed5c4 | |
| ToppCell | facs-Lung-nan-3m-Endothelial-Vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.24e-06 | 170 | 68 | 5 | 8e1f757ed62218c0fb6525f49d142dd2cd29acf9 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.18e-05 | 194 | 68 | 5 | 011e14d9ed1393275f892060e7708ffadcd0767f | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.18e-05 | 194 | 68 | 5 | 4a2c127c90d1fefe604fcb9e796577d21b489dd6 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.27e-05 | 197 | 68 | 5 | 0dd71e399f253787fa546a7e90c5373180b89ffd | |
| ToppCell | Control_saline|World / Treatment groups by lineage, cell group, cell type | 1.34e-05 | 199 | 68 | 5 | 11c9c1779caceb725ecccf3f23b7d4e6dbd1af64 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Vein|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.34e-05 | 199 | 68 | 5 | cfb624c7728046fc7f3ef071f57e4d7b013f3fef | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Vein|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.37e-05 | 200 | 68 | 5 | 7eb366b2c5394af7c77650bde6261e7dac67154e | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.37e-05 | 200 | 68 | 5 | 3dd022e974fec7013ba18f333da63f58fbf2dd7c | |
| ToppCell | LPS_only-Endothelial-Endothelial-Artery|LPS_only / Treatment groups by lineage, cell group, cell type | 1.37e-05 | 200 | 68 | 5 | b17eb1587ca86c3d40515128a00a8d8fd787fccf | |
| ToppCell | Control_saline-Endothelial-Endothelial-Vein|Control_saline / Treatment groups by lineage, cell group, cell type | 1.37e-05 | 200 | 68 | 5 | e5f876910bc8cb390d9b46a48d9b6d4d57235551 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Artery|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.37e-05 | 200 | 68 | 5 | 77ae679c35d3b9e2b620f34129f3a8d47e922c65 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.37e-05 | 200 | 68 | 5 | 58b38f9a484ee94191091a0659ed62ebed2d4a14 | |
| ToppCell | LPS-IL1RA+antiTNF-Unknown-Endothelial|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.98e-05 | 132 | 68 | 4 | 46c80eab16a70da9f363a9fbdf50bccab0b287d7 | |
| ToppCell | LPS-IL1RA+antiTNF-Unknown|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.98e-05 | 132 | 68 | 4 | a022c3c41654166cb106f27dc54fa88e8c40f898 | |
| ToppCell | 367C-Myeloid-Macrophage-SPP1+_Macrophage_2|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 6.99e-05 | 144 | 68 | 4 | 38ff324366ad5be626e3657c1e33277fc36ddd4c | |
| ToppCell | pdx-Tumor_cells-T9|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 6.99e-05 | 144 | 68 | 4 | 0b94d978262a826c9254145aa98c6c30240243f9 | |
| Drug | Ethotoin [86-35-1]; Down 200; 19.6uM; PC3; HT_HG-U133A | 1.34e-06 | 188 | 67 | 7 | 4545_DN | |
| Drug | plakin | 4.34e-06 | 82 | 67 | 5 | CID000018752 | |
| Drug | Myosmine [532-12-7]; Down 200; 27.4uM; PC3; HT_HG-U133A | 2.36e-05 | 195 | 67 | 6 | 3737_DN | |
| Drug | Isoconazole [27523-40-6]; Down 200; 9.6uM; PC3; HT_HG-U133A | 2.43e-05 | 196 | 67 | 6 | 2056_DN | |
| Drug | Meglumine [6284-40-8]; Up 200; 20.4uM; MCF7; HT_HG-U133A | 2.50e-05 | 197 | 67 | 6 | 5285_UP | |
| Drug | 1-amino-2-phosphonomethylcyclopropanecarboxylic acid | 2.55e-05 | 3 | 67 | 2 | ctd:C523415 | |
| Drug | Sulfasalazine [599-79-1]; Down 200; 10uM; PC3; HT_HG-U133A | 2.57e-05 | 198 | 67 | 6 | 6346_DN | |
| Drug | 2-Chloropyrazine [14508-49-7]; Down 200; 35uM; PC3; HT_HG-U133A | 2.72e-05 | 200 | 67 | 6 | 5750_DN | |
| Disease | unipolar depression, alcohol dependence | 7.21e-04 | 78 | 66 | 3 | EFO_0003761, MONDO_0007079 | |
| Disease | Sezary Syndrome | 1.67e-03 | 27 | 66 | 2 | C0036920 | |
| Disease | Myopia | 1.72e-03 | 385 | 66 | 5 | HP_0000545 | |
| Disease | Drug habituation | 2.21e-03 | 115 | 66 | 3 | C0013170 | |
| Disease | Substance-Related Disorders | 2.21e-03 | 115 | 66 | 3 | C0236969 | |
| Disease | Drug abuse | 2.21e-03 | 115 | 66 | 3 | C0013146 | |
| Disease | Drug Use Disorders | 2.21e-03 | 115 | 66 | 3 | C0013222 | |
| Disease | Drug Dependence | 2.21e-03 | 115 | 66 | 3 | C1510472 | |
| Disease | Substance Dependence | 2.21e-03 | 115 | 66 | 3 | C0038580 | |
| Disease | Substance Use Disorders | 2.21e-03 | 115 | 66 | 3 | C0038586 | |
| Disease | Organic Mental Disorders, Substance-Induced | 2.21e-03 | 115 | 66 | 3 | C0029231 | |
| Disease | Prescription Drug Abuse | 2.21e-03 | 115 | 66 | 3 | C4316881 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VNYDLRNWRLLIDQL | 691 | Q9UKU6 | |
| DYERAEWRENIREQQ | 851 | P11274 | |
| RTLDNNRRNIWFAEF | 351 | Q14833 | |
| VSLNELWNKYRERQR | 3596 | Q8TCU4 | |
| NRQFLDNLRDRLQEW | 626 | Q008S8 | |
| YHNVLSNWNRLRDRQ | 536 | Q92624 | |
| SNWNRLRDRQYSVTD | 541 | Q92624 | |
| RWQDRSSRENYLEEN | 951 | Q7L2E3 | |
| NYRRRFNIDEVLQEW | 426 | Q9UKL0 | |
| LWAYRDLQTREDIRN | 236 | O75323 | |
| RLNVIRNDNDSWDYT | 246 | Q8WVV9 | |
| LNRERLYWELSQLTN | 12471 | Q8WXI7 | |
| NLSDARYKESWRNLR | 1266 | Q86VF7 | |
| CQEADREELNYWIRR | 381 | Q06455 | |
| EENDSLRWQLDAYRN | 416 | Q16206 | |
| ILDYRNLNLEQWLFR | 151 | Q9HD23 | |
| VRRDFADWYLEQLNS | 326 | Q86VI3 | |
| SQRYRIQSEQFEDLW | 596 | Q3SYG4 | |
| AVDYNLTWQRNDRDV | 546 | Q96RW7 | |
| QLRQLFERDWSSRYA | 476 | Q96BZ4 | |
| QEIDLNDWQRHAIYR | 786 | Q96J02 | |
| NYFLNRDAQIRDSWL | 106 | O95400 | |
| RAAVSDELRQWYQRS | 921 | Q9P2Q2 | |
| RSLENNRRNIWFAEF | 346 | O15303 | |
| YLSCLQREENWQRRA | 141 | Q96BQ5 | |
| RAQQWRRARHNYNDL | 6 | O95467 | |
| LSERADWQYSQRELD | 91 | Q6PCB6 | |
| SEIDWQNSRRYIRNT | 141 | B2RV13 | |
| YQQRWLAIDANARRE | 76 | Q14974 | |
| LYNALEFWRQEELTR | 406 | Q8NA54 | |
| EYLSNADERLRWQAS | 3551 | Q14204 | |
| WLLDQYLEQRETSRN | 1396 | Q8IWT3 | |
| QLKNRYESRDREWAT | 761 | Q32P44 | |
| QEELRRQRYWLGEEQ | 96 | Q8IVE0 | |
| EENDSLRWQLDAYRN | 431 | Q8TC92 | |
| QVARESYLQWLRDQE | 401 | Q96G74 | |
| RDDRYWRLDQAKLQA | 481 | Q9H239 | |
| QSERNYLWREENAEQ | 466 | Q9UQE7 | |
| RQDWQAYQHRLSETR | 3576 | Q8NF91 | |
| ERWTNNFREYNLHRV | 201 | P03956 | |
| TQRWQRREISNFEYL | 2286 | Q8NFP9 | |
| DEKWILYDNRRRSAQ | 496 | Q53H47 | |
| LYDNRRRSAQWLDQE | 501 | Q53H47 | |
| FWNMYNSRRDLDINR | 201 | Q9ULP0 | |
| SQRALVYWQFQRRNE | 601 | Q14563 | |
| RRKDDAQQRSWALYE | 391 | Q9NZQ3 | |
| VRDAEDALYNLNRKW | 61 | Q8WXF0 | |
| EDLNAKWQRYNASRD | 221 | Q8NFZ5 | |
| EEWECLDSAQQRLYR | 16 | A8MUV8 | |
| EWQRLNPEQRNLYRD | 21 | Q96PE6 | |
| EEWQCLDTAQRNLYR | 16 | Q03936 | |
| EWTLLDQAQRDLYRD | 21 | Q147U1 | |
| ERVQYWIENYRNLLD | 691 | Q9NXC5 | |
| RIIQEWQSRNERYQA | 391 | Q5VZP5 | |
| ALLELWELRRQQYEQ | 451 | Q13813 | |
| WLRKQFYSVDRNRED | 156 | P19174 | |
| QEARLRQQWEQNSRY | 26 | Q9BT92 | |
| ANELQLRWQEYRELV | 411 | Q15149 | |
| QRAYWALLNQRRDQS | 641 | Q8IUG5 | |
| QEEWRLLDDAQRLLY | 26 | Q6PK81 | |
| WQDLDDAQRTLYRDV | 36 | Q9BY31 | |
| EEWEQLDLAQRTLYR | 26 | Q6NX49 | |
| EHYNRQEEWRRQLPE | 3731 | Q7Z7G8 | |
| DQQTEWQRYLRQSLE | 481 | Q96QU8 | |
| RDTYDAVLWLRNNRD | 461 | Q8IY18 | |
| EEWTLLDQTQRNLYR | 26 | Q9BR84 | |
| EEWECLDSAQQRLYR | 16 | B4DX44 | |
| LSYNQRSLQRWEKDE | 1996 | O14686 | |
| VWQNRFNYLEKARER | 486 | A6PVS8 | |
| NAKNRSDRLYREAWD | 2471 | P20929 |